Cilostazol, a cAMP phosphodiesterase 3 inhibitor, in the treatment of poststroke depression.
Nishimura
Katsuji
K
Ishigooka
Jun
J
Imamura
Yukiko
Y
Ihara
Shunichi
S
D000077407:Cilostazol; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000150:complications; D008297:Male; D008875:Middle Aged; D058987:Phosphodiesterase 3 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D020521:Stroke / Q000150:complications* / Q000523:psychology; D013777:Tetrazoles / Q000627:therapeutic use*
D058987:Phosphodiesterase 3 Inhibitors; D010726:Phosphodiesterase Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol